Newsletters
EARLEJNMMI Radiopharmacy and Chemistry
EJNMMI Radiopharmacy and Chemistry publishes new research in the field of development of new imaging and radionuclide-based therapeutic agents for application in nuclear medicine and molecular imaging.
The journal provides a platform for chemists, pharmacists and basic scientists to present their views and scientific work. In addition, the journal provides insight into novel concepts of imaging or radionuclide-based therapeutic agent applications of relevance for the whole molecular imaging community.
The journal reports original research articles, review papers, guidelines on the application of imaging or radionuclide therapy agents, editorials, and letters to the editor. The journal’s main focus is research articles on novel radiochemistry and new radiopharmaceuticals, including their first biological evaluation and molecular imaging agents, including optical imaging, MRI, and hybrid probes. To translate imaging and radionuclide therapy agents to the clinic, legislative issues related to their production and safety can also be presented in the form of guidelines or position papers.
Editor in Chief: Philip H. Elsinga